Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bayer, Versant close $225m Series A to launch stem cell company
Bayer, Versant close $225m Series A to launch stem cell company
Bayer, Versant close $225m Series A to launch stem cell company
Submitted by
admin
on December 13, 2016 - 1:20pm
Source:
Mass Device
News Tags:
Bayer
Versant Ventures
stem cells
Series A
BlueRock Therapeutics
devices
regenerative medicine
Headline:
Bayer, Versant close $225m Series A to launch stem cell company
Do Not Allow Advertisers to Use My Personal information
